Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAPP II: Arrhythmia Monitoring in Antipsychotic-Treated Patients
NCT04575103Unknown
- Sponsor
- Herlev & Gentofte Hospital
- Start
- Jan 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Open-label trial in schizophrenia, bipolar disorder (BD) and psychosis, sponsored by Herlev & Gentofte Hospital. Primary endpoint: Ventricular arrhythmias at 2 years. Status: unknown.
02
Conditions
schizophreniabipolar disorder (BD)psychosis
Beyond the preview
Go deeper on NCT04575103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04575103.